| Literature DB >> 27365927 |
Josna Vinutha Yadiki1, Sharada Reddy Jampanapalli2, Suhasini Konda3, Hema Chandrika Inguva4, Vamsi Krishna Chimata5.
Abstract
BACKGROUND: Chlorhexidine gluconate is a widely used antimicrobial agent. Adding chlorhexidine and quaternary ammonium compounds to filling materials, such as composite resins, acrylic resins, and glass ionomer cements increases the antibacterial property of restorative materials. This study includes antibacterial property of glass ionomer restorative cements with chlorhexidine gluconate. AIM: The primary objective of our study was to compare the antimicrobial properties of two commercially available glass ionomer cements with and without chlorhexidine gluconate on strains of mutans streptococci.Entities:
Keywords: Antimicrobial properties; Chlorhexidine gluconate; Glass ionomer cements.
Year: 2016 PMID: 27365927 PMCID: PMC4921875 DOI: 10.5005/jp-journals-10005-1342
Source DB: PubMed Journal: Int J Clin Pediatr Dent ISSN: 0974-7052
Fig. 1Zones of inhibition around restorative materials against Streptococcus mutans on day 1
Fig. 2Zones of inhibition around restorative materials against Streptococcus mutans on day 7
Fig. 3Zones of inhibition around restorative materials against Streptococcus mutans on day 14
Graph 1Comparison of mean inhibition zone of Fuji II with chlorhexidine gluconate vs Fuji II without chlorhexidine gluconate
Graph 2Comparison of mean inhibition zone of Fuji IX with chlorhexidine gluconate vs Fuji IX without chlorhexidine gluconate
Table 1: Mean values of inhibition zones (mm) of four groups of restorative materials against Streptococcus mutans
| Group A | 25.50 | 23.20 | 20.20 | 1.269 | 1.229 | 1.317 | <0.001* | ||||||||
| Group B | 24.70 | 22.80 | 19.70 | 0.949 | 0.632 | 1.252 | |||||||||
| Group C | 15.00 | 11.00 | 11.00 | 0.667 | 0.000 | 0.000 | |||||||||
| Group D | 13.60 | 11.00 | 11.00 | 0.516 | 0.000 | 0.000 | |||||||||
*Highly significant (p < 0.001)
Table 2: Comparison of intragroup change in inhibition zone from day 1 to 7 and then at day 14
| Group A | Day 1 | 2.30 ± 0.68 | 10.776 | <0.001* | |||||
| Day 1 | 5.30 ± 1.06 | 15.821 | <0.001* | ||||||
| Day 7 | 3.00 ± 0.67 | 14.230 | <0.001* | ||||||
| Group B | Day 1 | 1.90 ± 0.74 | 8.143 | <0.001* | |||||
| Day 1 | 5.00 ± 1.25 | 12.677 | <0.001* | ||||||
| Day 7 | 3.10 ± 0.99 | 9.858 | <0.001* | ||||||
| Group C | Day 1 | 4.00 ± 0.67 | 18.974 | <0.001* | |||||
| Day 1 | 4.00 ± 0.67 | 18.974 | <0.001* | ||||||
| Day 7 | – | – | – | ||||||
| Group D | Day 1 | 2.60 ± 0.52 | 15.922 | <0.001* | |||||
| Day 1 | 2.60 ± 0.52 | 15.922 | <0.001* | ||||||
| Day 7 | – | – | – |
*Highly significant (p < 0.001)
Graph 3Mean inhibition zone in four groups on days 1, 7, and 14